Department of Neurology, Stroke Center, Seoul National University Bundang Hospital, 300 Gumi-dong, Bundang-gu, Seongnam-si, Gyeonggi-do 463-707, Korea.
Stroke. 2012 Mar;43(3):764-9. doi: 10.1161/STROKEAHA.111.632182. Epub 2012 Jan 26.
Multidetector-row CT (MDCT) is emerging as a new tool for diagnosing aortic atherothrombotic disease (AAD). We elucidated whether MDCT-detected AAD is associated with an increased risk of early ischemic lesion recurrence on diffusion-weighted MRI after ischemic stroke.
A consecutive series of patients with acute ischemic stroke confirmed using diffusion-weighted MRI who were hospitalized within 48 hours after symptom onset and underwent MDCT were identified in a prospective stroke registry database. AAD on MDCT was defined as the presence of plaque formation that was noncalcified and ≥4 mm thick, ulcerative, or soft and thrombosed (vulnerable) in the proximal aortic arch. Ischemic lesion recurrence on diffusion-weighted MRI was defined as the occurrence of any new lesion separate from the index lesion on follow-up diffusion-weighted MRI performed within 14 days after symptom onset.
A total of 138 patients was selected. MDCT detected AAD in 24 of 138 (17.4%); ≥4 mm thickness in 17 of 138 (12.3%); ulcerated plaque in 20 of 138 (14.5%); and vulnerable plaque in 16 of 138 (11.6%). With respect to diffusion-weighted MRI lesion recurrence, the crude ORs (95% CIs) were as follows: AAD, 3.56 (1.43-8.89); vulnerable plaque, 3.21 (1.11-9.30); ulcerated plaque, 3.37 (1.27-8.95); and ≥4 mm thickness of the noncalcified plaque, 4.23 (1.11-16.19). These results remained significant after adjustments for potential confounders were made.
This study shows that AAD detected by MDCT increases the risk of early ischemic lesion recurrence after acute ischemic stroke, thus supporting the role of MDCT in diagnosing AAD and assessing its contribution to recurrence.
多排螺旋 CT(MDCT)作为一种新兴的工具,用于诊断主动脉粥样硬化血栓形成性疾病(AAD)。我们阐明了 MDCT 检测到的 AAD 是否与缺血性卒中后扩散加权 MRI 早期缺血性病变复发的风险增加相关。
我们从前瞻性卒中登记数据库中确定了一组连续的、经扩散加权 MRI 证实的急性缺血性卒中患者,这些患者在症状发作后 48 小时内住院并接受了 MDCT 检查。MDCT 上的 AAD 定义为非钙化斑块形成,厚度≥4mm,溃疡或软血栓形成(易损)的近端主动脉弓。扩散加权 MRI 上的缺血性病变复发定义为在症状发作后 14 天内进行的随访扩散加权 MRI 上出现任何与指数病变分离的新病变。
共选择了 138 例患者。MDCT 在 138 例患者中有 24 例(17.4%)检测到 AAD;138 例中有 17 例(12.3%)≥4mm 厚;138 例中有 20 例(14.5%)溃疡斑块;138 例中有 16 例(11.6%)易损斑块。关于扩散加权 MRI 病变复发,未经校正和校正潜在混杂因素后的粗比值比(95%可信区间)分别为:AAD,3.56(1.43-8.89);易损斑块,3.21(1.11-9.30);溃疡斑块,3.37(1.27-8.95);非钙化斑块≥4mm 厚,4.23(1.11-16.19)。这些结果在调整了潜在混杂因素后仍然显著。
本研究表明,MDCT 检测到的 AAD 增加了急性缺血性卒中后早期缺血性病变复发的风险,从而支持 MDCT 诊断 AAD 及其对复发的作用。